← All stocks

ADIAL PHARMACEUTICALS, INC.

ADIL Net selling
CIK 0001513525 #5135 in the set updated 18 Sep 2026
Bought (120 mo)
$559.05K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$948.50K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$948.50K
4 of 4 sales
Net
−$389.45K
−$389.45K against sales at will

By person

11 insiders · 33 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Johnson Bankole A.
Director
$240.61K (5)
$948.50K (4)
−$707.89K
872,720
$2.40M
−39.1%
Newman James W. Jr.
Director
$122.57K (9)
+$122.57K
313,107
$861.04K
+375.1%
Coastlands Capital LP entity
10% owner
$106.33K (5)
+$106.33K
388,308
$1.07M
+11.5%
Stilley William B. III
Director
$87.62K (5)
+$87.62K
1,393,920
$3.83M
+132.4%
Schuyler Kevin
Director
$1.92K (2)
+$1.92K
126,055
$346.65K
+450.5%
Gilliland Robertson H.
Director
(1)
$0.00
118,609
$326.17K
+81.1%
Goodman Tony
Chief Operating Officer
(1)
$0.00
26,523
$72.94K
Davidson Matt
Chief Development Officer
300,918
$827.52K
+19,914%
Truluck Joseph
Chief Financial Officer
265,139
$729.13K
+255.3%
Claiborne Cary J
Chief Executive Officer
40,417
$111.15K
Shah Vinay
Chief Financial Officer
17,325
$47.64K

No percentages here. This company's share count has moved by a factor of 16.8 over the window, from 1,427,970 to 23,987,587 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Coastlands Capital LP
16 Jul 2026
10% owner
Buy indirect
1,233
$2.75
$3.39K
Coastlands Capital LP
14 Jul 2026
10% owner
Buy indirect
2,000
$2.65
$5.30K
Coastlands Capital LP
10 Jul 2026
10% owner
Buy indirect
1,700
$2.70
$4.59K
Coastlands Capital LP
9 Jul 2026
10% owner
Buy indirect
10,053
$2.79
$28.05K
Coastlands Capital LP
29 Jun 2026
10% owner
Buy indirect
25,000
$2.60
$65.00K
Schuyler Kevin
29 Sep 2023
Director
Buy
700
$2.74
$1.92K
Newman James W. Jr.
30 Dec 2021
Director
Buy indirect
10,000
$2.71
$27.10K
Newman James W. Jr.
30 Dec 2021
Director
Buy indirect
5,000
$2.72
$13.60K
Newman James W. Jr.
30 Dec 2021
Director
Buy
10,000
$2.66
$26.60K
Stilley William B. III
30 Nov 2021
Chief Executive Officer
Buy
10,600
$2.75
$29.18K
Stilley William B. III
29 Nov 2021
Chief Executive Officer
Buy
10,000
$2.59
$25.89K
Newman James W. Jr.
26 Nov 2021
Director
Buy indirect
10,000
$2.85
$28.50K
Newman James W. Jr.
27 Mar 2020
Director
Buy indirect
4,644
$1.35
$6.27K
Newman James W. Jr.
27 Mar 2020
Director
Buy indirect
10,000
$1.34
$13.40K
Newman James W. Jr.
27 Mar 2020
Director
Buy
5,000
$1.42
$7.10K
Stilley William B. III
26 Mar 2020
Chief Executive Officer
Buy
12,652
$1.47
$18.60K
Stilley William B. III
25 Mar 2020
Chief Executive Officer
Buy
12,348
$1.13
$13.95K
Johnson Bankole A.
29 Mar 2019
Chief Medical Officer
Buy
600
$3.30
$1.98K
Johnson Bankole A.
29 Mar 2019
Chief Medical Officer
Buy
2,500
$3.47
$8.67K
Johnson Bankole A.
29 Mar 2019
Chief Medical Officer
Buy
30,000
$3.47
$104.15K
Johnson Bankole A.
28 Mar 2019
Chief Medical Officer
Buy
40,000
$3.15
$125.81K
Gilliland Robertson H.
31 Jul 2018
Director
Buy indirect
14,000
no price
Goodman Tony
31 Jul 2018
Director
Buy
7,000
no price
Johnson Bankole A.
31 Jul 2018
Director
Buy
1,400
no price
Newman James W. Jr.
31 Jul 2018
Director
Buy
10,000
no price
Newman James W. Jr.
31 Jul 2018
Director
Buy indirect
10,000
no price
Schuyler Kevin
31 Jul 2018
Director
Buy
90,000
no price
Stilley William B. III
31 Jul 2018
Chief Executive Officer
Buy
80,000
no price

What was left out

Form 4 filings counted 97
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 4
Transactions with no price 8
Shares from compensation/vesting 4,157,905
Sales filed before the plan box existed 4
History held since 2 Aug 2018